SINGAPORE, June 18, 2026 — POLARISQB TECHNOLOGIES GROUP PTE. LTD. (“PTG”) and Polaris Quantum Biotech, Inc. (“PolarisQB“) today announced an exclusive Representation Agreement covering Greater China and Southeast Asia.

Under the agreement, PTG will serve as PolarisQB’s exclusive representative across Mainland China, Hong Kong SAR, Macau SAR, Taiwan, and the ten member states of the Association of Southeast Asian Nations (ASEAN): Brunei Darussalam, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam.

In this role, PTG will identify, develop, and facilitate commercial opportunities and strategic relationships across the territory: engaging pharmaceutical companies, research and development organizations, and contract research organizations (CROs). Drawing on its experience in cross-border commercialization and market entry, PTG will anchor PolarisQB’s regional business development and commercial engagement.

“I have had the privilege of supporting PolarisQB since its early days, and watching the company mature into a true pioneer of quantum-powered drug discovery has only deepened my conviction in its future,” said Ms. Xu, Director of Business Development at PTG. “I believe PolarisQB has a remarkable road ahead, and I am proud that we can now help open new markets and bring its breakthrough platform to partners across Greater China and ASEAN.”

The agreement positions PolarisQB’s quantum-powered drug discovery platform, QuADD, to reach one of the world’s fastest-growing biopharmaceutical markets, while establishing a durable framework for long-term collaboration between the two companies. QuADD uses quantum annealing and quantum‑inspired algorithms to explore ultra‑large chemical spaces, on the order of 10^30 candidate molecules, and optimize multi‑parameter objectives such as binding affinity, drug‑likeness, and synthetic feasibility in hours instead of months. PolarisQB has demonstrated that its QuADD engine outperforms generative AI methods in both the quality of initial leads and the speed of molecular design, providing clear evidence that quantum annealing is a superior alternative to standard artificial intelligence.